Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy. [electronic resource]
Producer: 20181026Description: 358-368 p. digitalISSN:- 1528-1167
- Animals
- Anticonvulsants -- pharmacology
- Atrioventricular Block
- Behavior, Animal
- Bradycardia
- Carbamates -- pharmacology
- Channelopathies
- Death, Sudden
- Disease Models, Animal
- Drug Resistance
- Drug Resistant Epilepsy -- drug therapy
- Electroencephalography
- Epilepsy -- drug therapy
- Gene Expression Profiling
- Heart Rate -- drug effects
- KCNQ Potassium Channels -- agonists
- KCNQ1 Potassium Channel -- genetics
- KCNQ2 Potassium Channel -- genetics
- KCNQ3 Potassium Channel -- genetics
- Kv1.1 Potassium Channel -- genetics
- Mice
- Nerve Tissue Proteins -- genetics
- Pharmacogenetics
- Pharmacogenomic Testing
- Phenylenediamines -- pharmacology
- RNA, Messenger -- metabolism
- Transcriptome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.